New improper payments report shows rise in clinical lab denials

Why This Topic Matters

It highlights where Medicare improper payment denials are concentrated and why documentation and billing oversight matter for laboratory and other Part B services. Readers can use it to decide whether to review CMS appendices, OIG materials, or contractor guidance for current audit and denial trends.

Article Sections

1. CMS improper payments report overview

   Introduces the Medicare Fee-for-Service improper payments appendices and explains the focus on Part B service types with higher denial activity.

2. Clinical laboratory denials and oversight context

   Discusses laboratory-related denial trends in relation to CMS, OIG, and contractor review activity, along with general documentation and billing oversight themes.

3. Contractor guidance and CERT resources

   Points readers to Medicare contractor materials and CERT-related resources used to track documentation issues and denial patterns.

4. Top Part B service types in the report

   Presents the article’s summarized ranking of Part B service categories and associated improper payment breakdowns from the CMS appendices.